EDMUND HARRIGAN
CIK 1177917 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.38M
Companies
5
Total Filings
64
Lifetime Open-Market Net
-$4.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 22,764 | $108.53 | $2.47M | $0 | 34 | 2026-06-10 |
| ACAD | Director | 43,148 | $21.09 | $910.0K | $33.0K | 14 | 2026-06-01 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 6,000 | $0.07 | $421 | $24.7K | 6 | 2022-05-20 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 55,163 | $329.83 | $18.19M | -$4.52M | 6 | 2020-08-14 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Director | — | $0.07 | — | $0 | 3 | 2019-06-14 |
Recent Filings · Page 7 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-14 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2016-08-18 | ACAD | Buy (P) | +1,000 | $33.0K | EDGAR |
| 2016-06-10 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2015-11-30 | ACAD | Grant (A) | — | $0 | EDGAR |
Showing 61–64 of 64
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.